Neurocrine Biosciences Inc
NBIXNasdaqCIK 914475HealthcareFiscal year ends Dec 31
Reports and events: 286 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2816:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000914475-26-000045 |
| 2026-07-3116:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-26-328470 |
| 2026-07-3121:22 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000914475-26-000037 |
| 2026-07-3016:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-26-000035 |
| 2026-05-2816:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000914475-26-000029 |
| 2026-05-1809:04 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-228013 |
| 2026-05-0516:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000914475-26-000026 |
| 2026-05-0516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-26-000025 |
| 2026-04-1516:15 ET | DEF 14A | Proxy statementPeriod 2026-04-15 | 0000914475-26-000015 |
| 2026-04-0607:35 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-142904 |
| 2026-02-1116:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000914475-26-000007 |
| 2026-02-1116:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-26-000006 |
| 2025-11-2416:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000914475-25-000186 |
| 2025-10-2816:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000914475-25-000181 |
| 2025-10-2816:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-25-000180 |
| 2025-07-3016:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000914475-25-000158 |
| 2025-07-3016:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-25-000157 |
| 2025-05-3016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000914475-25-000139 |
| 2025-05-2216:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000914475-25-000120 |
| 2025-05-0516:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000914475-25-000100 |
| 2025-05-0516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-25-000099 |
| 2025-04-0916:04 ET | DEF 14A | Proxy statementPeriod 2025-04-09 | 0000914475-25-000091 |
| 2025-04-0408:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914475-25-000081 |
| 2025-02-1016:51 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000914475-25-000037 |
| 2025-02-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-25-000034 |
| 2025-01-2716:12 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000914475-25-000006 |
| 2024-12-2008:06 ET | 8-K | 8.01 Other events | 0000914475-24-000229 |
| 2024-11-0108:31 ET | 8-K | 8.01 Other events | 0000914475-24-000214 |
| 2024-10-3007:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000914475-24-000211 |
| 2024-10-3007:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-24-000210 |
| 2024-10-1116:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000914475-24-000206 |
| 2024-08-2807:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000914475-24-000199 |
| 2024-08-0107:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000914475-24-000181 |
| 2024-08-0107:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-24-000180 |
| 2024-05-2816:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-148107 |
| 2024-05-2316:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000914475-24-000140 |
| 2024-05-0107:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000914475-24-000117 |
| 2024-05-0107:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-24-000116 |
| 2024-04-1016:07 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0000914475-24-000106 |
| 2024-02-0917:29 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000914475-24-000054 |
| 2024-02-0707:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-24-000033 |
| 2023-11-1307:01 ET | 8-K | 8.01 Other events | 0000914475-23-000078 |
| 2023-11-0917:03 ET | 8-K | 8.01 Other events | 0000914475-23-000075 |
| 2023-10-3107:02 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000914475-23-000073 |
| 2023-10-3107:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-23-000072 |
| 2023-10-0609:00 ET | 8-K | 8.01 Other events | 0000914475-23-000067 |
| 2023-10-0507:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000914475-23-000065 |
| 2023-09-1207:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000914475-23-000062 |
| 2023-08-0107:03 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000914475-23-000057 |
| 2023-08-0107:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000914475-23-000056 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:54 ET. Listed shows no prices and gives no investment advice.